Sergey Raskin

544 total citations
17 papers, 352 citations indexed

About

Sergey Raskin is a scholar working on Psychiatry and Mental health, Philosophy and Pharmacology. According to data from OpenAlex, Sergey Raskin has authored 17 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 5 papers in Philosophy and 4 papers in Pharmacology. Recurrent topics in Sergey Raskin's work include Schizophrenia research and treatment (7 papers), Mental Health and Psychiatry (5 papers) and Mental Health Treatment and Access (4 papers). Sergey Raskin is often cited by papers focused on Schizophrenia research and treatment (7 papers), Mental Health and Psychiatry (5 papers) and Mental Health Treatment and Access (4 papers). Sergey Raskin collaborates with scholars based in Israel. Sergey Raskin's co-authors include John Nelson, Rimona Durst, Grégory Katz, Haim Y. Knobler, Josef Zislin, Tali Bdolah‐Abram, Yehuda Neumark, Paula Rosca, Moshe Z. Abramowitz and Tzipi Hornik‐Lurie and has published in prestigious journals such as Acta Psychiatrica Scandinavica, Journal of Clinical Psychopharmacology and Administration and Policy in Mental Health and Mental Health Services Research.

In The Last Decade

Sergey Raskin

17 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sergey Raskin Israel	8	150	67	59	52	45	17	352
G. Bersani Italy	9	120 0.8×	60 0.9×	105 1.8×	22 0.4×	14 0.3×	18	416
Goran Dodig Croatia	11	63 0.4×	28 0.4×	42 0.7×	64 1.2×	11 0.2×	26	311
Ashley H. Robins South Africa	8	178 1.2×	101 1.5×	24 0.4×	33 0.6×	13 0.3×	16	468
S Puźyński Poland	11	138 0.9×	46 0.7×	12 0.2×	39 0.8×	7 0.2×	58	339
Marta Martín-Subero Spain	8	72 0.5×	21 0.3×	22 0.4×	35 0.7×	8 0.2×	12	433
S Mukherjee India	7	129 0.9×	10 0.1×	30 0.5×	34 0.7×	23 0.5×	18	312
Sabine Riemer Germany	9	88 0.6×	30 0.4×	34 0.6×	37 0.7×	13 0.3×	13	294
Ahmad-Ali Noorbala Iran	9	102 0.7×	44 0.7×	24 0.4×	29 0.6×	5 0.1×	16	370
Tobias Wustmann Germany	7	105 0.7×	7 0.1×	76 1.3×	55 1.1×	44 1.0×	14	284
N. Bergemann Germany	9	150 1.0×	44 0.7×	7 0.1×	20 0.4×	8 0.2×	23	329

Countries citing papers authored by Sergey Raskin

Since Specialization

Citations

This map shows the geographic impact of Sergey Raskin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergey Raskin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergey Raskin more than expected).

Fields of papers citing papers by Sergey Raskin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergey Raskin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergey Raskin. The network helps show where Sergey Raskin may publish in the future.

Co-authorship network of co-authors of Sergey Raskin

This figure shows the co-authorship network connecting the top 25 collaborators of Sergey Raskin. A scholar is included among the top collaborators of Sergey Raskin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergey Raskin. Sergey Raskin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Neumark, Yehuda, et al.. (2020). Differential Effect of Community Rehabilitation Reform on Hospitalizations of Patients with Chronic Psychotic Disorders With and Without Substance Use Disorder, Israel, 1991–2016. Administration and Policy in Mental Health and Mental Health Services Research. 48(2). 354–362. 6 indexed citations

2.

Nelson, John & Sergey Raskin. (2019). The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease. Postgraduate Medicine. 131(4). 268–277. 110 indexed citations

3.

Rosca, Paula, et al.. (2019). Psychiatric Hospitalizations of Chronic Psychotic Disorder Patients With and Without Dual Diagnosis, Israel, 1963–2016. Journal of Dual Diagnosis. 15(3). 130–139. 9 indexed citations

4.

Raskin, Sergey, et al.. (2017). [CO-OCCURRING SCHIZOPHRENIA AND SUBSTANCE USE DISORDER: ETIOLOGICAL THEORIES AND CHALLENGES IN ISRAEL].. PubMed. 156(11). 715–719. 3 indexed citations

5.

Katz, Grégory, et al.. (2017). Impulsivity, Sensation Seeking and Anhedonia as Possible Explanations for Cannabis Abuse Comorbidity among First Psychotic Episode Inpatients. Journal of Addiction Research & Therapy. 8(2). 3 indexed citations

6.

Katz, Grégory, et al.. (2016). Cannabis and Alcohol Abuse Among First Psychotic Episode Inpatients.. PubMed. 53(3). 10–15. 6 indexed citations

7.

Katz, Grégory, et al.. (2014). Cannabis Withdrawal - A New Diagnostic Category in DSM-5.. PubMed. 51(4). 270–5. 16 indexed citations

8.

Gardiner, A., Kailash P. Bhatia, Russell C. Dale, et al.. (2012). Prrt2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway). 5 indexed citations

9.

Raskin, Sergey & Rimona Durst. (2010). Bupropion as the treatment of choice in depression associated with Parkinson’s disease and it’s various treatments. Medical Hypotheses. 75(6). 544–546. 33 indexed citations

10.

Rodionov, Valentin O., et al.. (2009). Wavelet Analysis of the Frontal Auditory Evoked Potentials Obtained in the Passive Oddball Paradigm in Healthy Subjects and Schizophrenics. Journal of Basic and Clinical Physiology and Pharmacology. 20(3). 233–264. 3 indexed citations

11.

Zislin, Josef, et al.. (2007). [Multisensory environmental intervention (snoezelen) as a preventive alternative to seclusion and restraint in closed psychiatric wards].. PubMed. 146(1). 11–4, 79. 7 indexed citations

12.

Raskin, Sergey, et al.. (2005). [Legal involvement in psychiatric care].. PubMed. 144(10). 696–9, 751. 2 indexed citations

13.

Zislin, Josef, et al.. (2002). Male Genital Self-Mutilation in the Context of Religious Belief: The Jerusalem Syndrome. Transcultural Psychiatry. 39(2). 257–264. 7 indexed citations

14.

Raskin, Sergey, Rimona Durst, Grégory Katz, & Josef Zislin. (2000). Olanzapine and Sulpiride: A Preliminary Study of Combination/Augmentation in Patients With Treatment-Resistant Schizophrenia. Journal of Clinical Psychopharmacology. 20(5). 500–503. 26 indexed citations

15.

Durst, Rimona, et al.. (2000). Risperidone in treating behavioural disturbances of Prader‐Willi syndrome. Acta Psychiatrica Scandinavica. 102(6). 461–465. 33 indexed citations

16.

Raskin, Sergey, et al.. (2000). Clozapine and risperidone: combination/ augmentation treatment of refractory schizophrenia: a preliminary observation. Acta Psychiatrica Scandinavica. 101(4). 334–336. 48 indexed citations

17.

Raskin, Sergey, et al.. (2000). Clozapine and risperidone: combination/ augmentation treatment of refractory schizophrenia: a preliminary observation. Acta Psychiatrica Scandinavica. 101(4). 334–336. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact